Júlia Companys‐Alemany

Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease

Christian Griñán‐Ferré, Sandra Codony, Eugènia Pujol et al. · Neurotherapeutics · 2020 · 78 citations · Full text

Soluble Epoxide Hydrolase, Alzheimer's Disease, Biochemistry +13

Environmental Enrichment Modified Epigenetic Mechanisms in SAMP8 Mouse Hippocampus by Reducing Oxidative Stress and Inflammaging and Achieving Neuroprotection

Christian Griñán‐Ferré, Dolors Puigoriol‐Illamola, Verónica Palomera‐Ávalos et al. · Frontiers in Aging Neuroscience · 2016 · 66 citations · Full text

A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice

Júlia Companys‐Alemany, Andreea L. Turcu, Aina Bellver‐Sanchís et al. · Pharmaceutics · 2020 · 60 citations · Full text

NMDA receptor antagonists reduce amyloid-β deposition by modulating calpain-1 signaling and autophagy, rescuing cognitive impairment in 5XFAD mice

Júlia Companys‐Alemany, Andreea L. Turcu, Marion Schneider et al. · Cellular and Molecular Life Sciences · 2022 · 36 citations · Full text

Autophagy Rescue, Calpain-1 Signaling, Autophagy Activation +25

Temporal Integrative Analysis of mRNA and microRNAs Expression Profiles and Epigenetic Alterations in Female SAMP8, a Model of Age-Related Cognitive Decline

Marta Cosín‐Tomás, María Jesús Álvarez‐López, Júlia Companys‐Alemany et al. · Frontiers in Genetics · 2018 · 32 citations · Full text